Author Question: In a Master Test Plan, milestones, schedules, and locations fall under which category? A) Overall ... (Read 23 times)

jwb375

  • Hero Member
  • *****
  • Posts: 540
In a Master Test Plan, milestones, schedules, and locations fall under which category?
 
  A) Overall Plan
  B) Testing Requirements
  C) Procedure Control
  D) Introduction

Question 2

What information is required to design the physical files and databases related to the project?
 
  What will be an ideal response?


yahahah24021

  • Sr. Member
  • ****
  • Posts: 323
Answer to Question 1

A

Answer to Question 2

This information includes the following:
 Normalized relations, including volume estimates
 Definitions of each attribute
 Descriptions of where and when data are used: entered, retrieved, deleted, and updated (including frequencies)
 Expectations or requirements for response time and data integrity
 Descriptions of the technologies used for implementing the files and database so that the range of required decisions and choices for each is known.
Normalized relations are the result of logical database design. We take a bottom-up approach to reviewing physical file and database design.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The U.S. Pharmacopeia Medication Errors Reporting Program states that approximately 50% of all medication errors involve insulin.

Did you know?

Symptoms of kidney problems include a loss of appetite, back pain (which may be sudden and intense), chills, abdominal pain, fluid retention, nausea, the urge to urinate, vomiting, and fever.

Did you know?

Oxytocin is recommended only for pregnancies that have a medical reason for inducing labor (such as eclampsia) and is not recommended for elective procedures or for making the birthing process more convenient.

Did you know?

According to the FDA, adverse drug events harmed or killed approximately 1,200,000 people in the United States in the year 2015.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library